GlassScriptPhysician profile
Tapan B Jadav
NPI 1962628784
$1,594.46
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $465 · 2021: $471.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $262.91 | 2019-2020 | |
| Amgen INC. | $211.58 | 2019-2021 | |
| Pfizer INC. | $153.14 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.41 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $103.16 | 2020-2021 | |
| Astellas Pharma US INC | $100.66 | 2019-2020 | |
| Allergan, INC. | $80.03 | 2019-2020 | |
| Abbvie INC. | $77.81 | 2021 | |
| Amarin Pharma, INC. | $59.20 | 2019-2020 | |
| Grifols USA, LLC | $45.58 | 2020 | |
| Lilly USA, LLC | $36.98 | 2020 | |
| Esperion Therapeutics, INC. | $31.71 | 2020 | |
| Mylan Specialty L.P. | $31.32 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.50 | 2019-2021 | |
| Abbott Laboratories | $28.92 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $28.37 | 2021 | |
| Horizon Therapeutics Plc | $26.92 | 2019 | |
| Jazz Pharmaceuticals INC. | $24.15 | 2020 | |
| Daiichi Sankyo INC. | $23.38 | 2020 | |
| Gilead Sciences, INC. | $20.19 | 2021 | |
| Nestle Healthcare Nutrition INC. | $18.39 | 2021 | |
| Eisai INC. | $17.70 | 2020 | |
| Hologic Sales and Service, LLC | $15.55 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.96 | 2021 | |
| Tactile Systems Technology INC | $12.60 | 2020 | |
| Novo Nordisk INC | $12.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tapan Jadav listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.